시장보고서
상품코드
1264064

세계의 경비 약물전달 기술 시장(2023-2033년)

Nasal Drug Delivery Technology Market Report 2023-2033

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 397 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 경비 약물전달 기술 시장 규모는 2022년에 700억 달러를 돌파하며, 2033년까지 7.5%의 CAGR로 성장할 것으로 예측되고 있습니다. 우수한 약물전달 방법에 대한 수요의 급증, 제품 포장과 개발의 진보는 시장의 성장을 촉진하고 있습니다.

세계의 경비 약물전달 기술 시장에 대해 조사했으며, 시장 역학, 시장 동향, 기업 개요 등의 정보를 제공하고 있습니다.

목차

제1장 리포트의 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 시장 기회
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
    • 공급 기업의 교섭력
    • 구매자의 교섭력
    • 경쟁 기업간 경쟁 관계
    • 대체품으로부터의 위협
    • 신규 진출업체의 위협
  • PEST 분석

제4장 경비 약물전달 기술 시장 분석 : 컨테이너별

  • 주요 조사 결과
  • 컨테이너 부문 : 시장 매력 지수
  • 경비 약물전달 기술의 시장 규모 추정과 예측 : 컨테이너별
  • 가압 용기
  • 비가압 용기

제5장 경비 약물전달 기술 시장 분석 : 시스템별

  • 주요 조사 결과
  • 시스템 부문 : 시장 매력 지수
  • 경비 약물전달 기술의 시장 규모 추정과 예측 : 시스템별
  • 2회 용량
  • 다회용량
  • 단일 용량

제6장 경비 약물전달 기술 시장 분석 : 제형별

  • 주요 조사 결과
  • 제형 부문 : 시장 매력 지수
  • 경비 약물전달 기술의 시장 규모 추정과 예측 : 제형별
  • 비강용 스프레이
  • 점비약
  • 비강용 젤
  • 비강용 파우더
  • 기타

제7장 경비 약물전달 기술 시장 분석 : 용도별

  • 주요 조사 결과
  • 용도 부문 : 시장 매력 지수
  • 경비 약물전달 기술의 시장 규모 추정과 예측 : 용도별
  • 호흡기질환
    • 알레르기성 비염
    • 코 막힘
    • 천식
    • 기타
  • 비호흡기질환
    • 알츠하이머병
    • 심혈관질환
    • 신경 정신질환
    • 기타

제8장 경비 약물전달 기술 시장 분석 : 최종사용자별

  • 주요 조사 결과
  • 최종사용자 부문 : 시장 매력 지수
  • 경비 약물전달 기술의 시장 규모 추정과 예측 : 최종사용자별
  • 재택의료
  • 병원
  • 전문 클리닉
  • 예방접종 센터
  • 외래 수술 센터
  • 기타

제9장 경비 약물전달 기술 시장 분석 : 지역별

  • 주요 조사 결과
  • 시장 규모 추정과 예측 : 지역별

제10장 북미의 경비 약물전달 기술 시장 분석

제11장 유럽의 경비 약물전달 기술 시장 분석

제12장 아시아의 경비 약물전달 기술 시장 분석

제13장 라틴아메리카의 경비 약물전달 기술 시장 분석

제14장 중동·아프리카의 경비 약물전달 기술 시장 분석

제15장 기업 개요

  • 경쟁 구도(2022년)
  • 전략 전망
  • Becton, Dickinson, and Company
  • GSK plc
  • Johnson &Johnson
  • Merck &Co., Inc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • AptarGroup, Inc
  • AstraZeneca PLC
  • Presspart Verwaltungs GmbH
  • Recipharm AB
  • Neurelis Inc.
  • PendoPharm Inc.
  • Naveh Pharma Ltd.
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Nemera
  • Teleflex Incorporated
  • Optinose US, Inc
  • Flo Nasal Solution
  • Bayer AG

제16장 결론과 제안

  • 결론
  • 시장 관계자에 대한 권장사항
KSA 23.05.03

The global Nasal Drug Delivery Technology market is projected to grow at a CAGR of 7.5% by 2033

The Nasal Drug Delivery Technology Market Report 2022-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Alternative Drug Delivery Methods Coupled with Advancements In Product Development Driving Market Growth

Some of the major forces propelling the nasal drug delivery technology market include surge in demand for better drug delivery methods, and advancements in product packing and development. Furthermore, rising prevalence of allergic rhinitis and increasing cases of asthma are expected to propel market growth. On the other hand, rise in adoption of generic nasal delivery drugs coupled with new launches are expected to further boost market growth. Developing a successful nasal drug product requires expertise in a variety of areas, including formulation development, device design, clinical trial design, regulatory compliance, and commercialization. Market players are entering into strategic partnerships such as agreement and mergers to meet the growing market demand for effective nasal drugs. Many pharmaceutical companies developing a nasal drug product are partnering with a device manufacturer to design and manufacture a nasal delivery device that is optimized for the specific drug formulation.

On the other hand, production of pharmaceutical products is subject to strict consumer safety regulations. Before a product is finally marketed, lengthy and laborious processes are typically required for medical device and medicine approvals. Companies who engage in significant R&D to introduce new items to the market typically find this to be a hurdle. These stringent regulations are anticipated to hinder the growth of this market over the forecast period.

Complications with Nasal Drug Overuse Likely to Challenge Market Growth

Overuse of nasal drugs can lead to a variety of side effects, some of which can be serious. Rebound congestion, nosebleed, and irritation of nasal membrane are some of the side effects of nasal spray overuse. Many people mistakenly believe that nasal sprays are safe to use since they are widely accessible as over-the-counter medications, and they are ignorant of the potential side effects and addiction linked to them. Regular nasal spray users are prone to developing a habit of abusing the medicine. When their symptoms get worse, people take the prescription more frequently, which frequently results in rhinitis medicamentosa, a disorder. This frequently leads to a condition known as septal perforation-a hole in the inner wall of the nose-in situations of misuse.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Nasal Drug Delivery Technology Market evolving?
  • What is driving and restraining the nasal drug delivery technology market?
  • How will each nasal drug delivery technology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each nasal drug delivery technology submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading nasal drug delivery technology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the nasal drug delivery technology projects for these leading companies?
  • How will the industry evolve during the period between 2022 and 2033? What are the implications of nasal drug delivery technology projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the nasal drug delivery technology market?
  • Where is the nasal drug delivery technology market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the nasal drug delivery technology market today, and over the next 10 years:

  • Our 397-page report provides 141 tables and 251 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Nasal Drug Delivery Technology Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising nasal drug delivery technology prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Container

  • Pressurized Containers
  • Non-pressurized Containers

System

  • Nasal Bi Dose
  • Nasal Multi Dose
  • Nasal Unidose

Dosage Form

  • Nasal Spray
  • Nasal Drops and Liquids
  • Nasal Gels
  • Nasal Powder
  • Others

Application

  • Respiratory Diseases

Allergic Rhinitis

Nasal Congestion

Asthma

Others

  • Non-respiratory Diseases

Alzheimer's

Cardiovascular Disorders

Neuropsychiatry

Others

End-users

  • Home Health Care
  • Hospitals
  • Specialty Clinics
  • Vaccination Centres
  • Ambulatory Surgical Centres
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 29 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Turkey
  • Egypt
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Nasal Drug Delivery Technology Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • AptarGroup, Inc
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson, and Company
  • Dr. Reddy's Laboratories Ltd.
  • Flo Nasal Solution
  • GlaxoSmithKline PLC
  • H&T Presspart
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Naveh Pharma Ltd
  • Nemera
  • Novartis AG
  • Neurelis Inc.
  • OptiNose, Inc.
  • Pfizer Inc.
  • PendoPharm Inc.
  • Recipharm AB
  • Teleflex, Inc.
  • Teva Pharmaceutical Industries Ltd.

Overall world revenue for Nasal Drug Delivery Technology Market, 2023 to 2033 in terms of value the market will surpass US$70 billion in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Nasal Drug Delivery Technology Market, 2023 to 2033 report help you?

In summary, our 397-page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Nasal Drug Delivery Technology Market, 2023 to 2033 Market, with forecasts for containers, system, dosage form, application, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 30 key national markets - See forecasts for the Nasal Drug Delivery Technology Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Nasal Drug Delivery Technology Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Nasal Drug Delivery Technology Market, 2023 to 2033, market-leading companies. You will find data, trends, and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Nasal drug delivery technology market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 High Prevalence of Allergic Rhinitis to Spur Demand
      • 3.2.1.2 Multiple Benefits Associated with Multi-dose Nasal Spray Packaging to Boost Industry Growth
      • 3.2.1.3 Chronic Respiratory Diseases Driving Market Growth
      • 3.2.1.4 Need for Generic Inhalation and Nasal Spray Drugs to Boost Industry Growth
      • 3.2.1.5 Support from Government and NGOs for Respiratory Diseases Healthcare Awareness to Spur Market Growth
      • 3.2.1.6 Advanced Inhalation Methods to Augment Market Growth
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Product Development Regulations Likely to Restrain Market Growth
      • 3.2.2.2 Complications Associated with the Overuse of Nasal Sprays
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Emerging Opportunities for Nasal Devices
      • 3.2.3.2 Nasal Drug Delivery Has Evolved into a Highly Versatile Method of Administration for Locally Acting And Systemic Drugs
      • 3.2.3.3 Rising Demand for Generic Drugs is Expected to Enhance Market Growth
      • 3.2.3.4 DPI Technology Driving the Adoption of Nasal Drugs
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Nasal Drug Delivery Technology Market Analysis by Containers

  • 4.1 Key Findings
  • 4.2 Container Segment: Market Attractiveness Index
  • 4.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 4.4 Pressurized Containers
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Non-pressurized Containers
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Nasal Drug Delivery Technology Market Analysis by System

  • 5.1 Key Findings
  • 5.2 System Segment: Market Attractiveness Index
  • 5.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 5.4 Nasal Bi Dose
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Nasal Multi Dose
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Nasal Unidose
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Nasal Drug Delivery Technology Market Analysis By Dosage Form

  • 6.1 Key Findings
  • 6.2 Dosage Form Segment: Market Attractiveness Index
  • 6.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 6.4 Nasal Spray
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Nasal Drops and Liquid
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Nasal Gels
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Nasal Powder
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Others
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Nasal Drug Delivery Technology Market Analysis by Application

  • 7.1 Key Findings
  • 7.2 Application Segment: Market Attractiveness Index
  • 7.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 7.4 Respiratory Diseases
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.3 Allergic Rhinitis
      • 7.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.3.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.4 Nasal Congestion
      • 7.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.4.5 Asthma
      • 7.4.5.1 FDA Approved First Generic of Symbicort to Treat Asthma and COPD
      • 7.4.5.2 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.5.3 Market Share by Region, 2023 & 2033 (%)
    • 7.4.6 Others
      • 7.4.6.1 COPD
      • 7.4.6.2 Lupin Launched Nasal Drug For Breathing Problems In United States
      • 7.4.6.3 Covid 19
      • 7.4.6.4 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.4.6.5 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Non-respiratory Diseases
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.3 Alzheimer's
      • 7.5.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.3.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.4 Cardiovascular Disorders
      • 7.5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.4.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.5 Neuropsychiatry
      • 7.5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.5.2 Market Share by Region, 2023 & 2033 (%)
    • 7.5.6 Others
      • 7.5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 7.5.6.2 Market Share by Region, 2023 & 2033 (%)

8 Nasal Drug Delivery Technology Market Analysis by End-users

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 8.4 Home Health Care
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Hospitals
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Speciality Clinics
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Vaccination Centres
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)
  • 8.8 Ambulatory Surgical Centres
    • 8.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.8.2 Market Share by Region, 2023 & 2033 (%)
  • 8.9 Others
    • 8.9.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 8.9.2 Market Share by Region, 2023 & 2033 (%)

9 Nasal Drug Delivery Technology Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Nasal Drug Delivery Technology Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Nasal Drug Delivery Technology Market Attractiveness Index
  • 10.3 North America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 10.4 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 10.5 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 10.6 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 10.7 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 10.8 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 10.9 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 10.10 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 10.11 North America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 10.12 U.S. Nasal Drug Delivery Technology Market Analysis
  • 10.13 Canada Nasal Drug Delivery Technology Market Analysis

11 European Nasal Drug Delivery Technology Market Analysis

  • 11.1 Key Findings
  • 11.2 European Nasal Drug Delivery Technology Market Attractiveness Index
  • 11.3 European Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 11.4 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 11.5 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 11.6 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 11.7 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 11.8 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 11.9 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 11.10 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 11.11 European Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 11.12 Germany Nasal Drug Delivery Technology Market Analysis
  • 11.13 UK Nasal Drug Delivery Technology Market Analysis
  • 11.14 France Nasal Drug Delivery Technology Market Analysis
  • 11.15 Italy Nasal Drug Delivery Technology Market Analysis
  • 11.16 Spain Nasal Drug Delivery Technology Market Analysis
  • 11.17 Russia Nasal Drug Delivery Technology Market Analysis
  • 11.18 Netherlands Nasal Drug Delivery Technology Market Analysis
  • 11.19 Switzerland Nasal Drug Delivery Technology Market Analysis
  • 11.20 Rest of Europe Nasal Drug Delivery Technology Market Analysis

12 Asia Nasal Drug Delivery Technology Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Nasal Drug Delivery Technology Market Attractiveness Index
  • 12.3 Asia Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 12.4 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 12.5 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 12.6 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 12.7 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 12.8 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 12.9 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 12.10 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 12.11 Asia Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 12.12 Japan Nasal Drug Delivery Technology Market Analysis
  • 12.13 China Nasal Drug Delivery Technology Market Analysis
  • 12.14 India Nasal Drug Delivery Technology Market Analysis
  • 12.15 Australia Nasal Drug Delivery Technology Market Analysis
  • 12.16 South Korea Nasal Drug Delivery Technology Market Analysis
  • 12.17 Singapore Nasal Drug Delivery Technology Market Analysis
  • 12.18 Thailand Nasal Drug Delivery Technology Market Analysis
  • 12.19 Rest of Asia Nasal Drug Delivery Technology Market Analysis

13 Latin America Nasal Drug Delivery Technology Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Nasal Drug Delivery Technology Market Attractiveness Index
  • 13.3 Latin America Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 13.4 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 13.5 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 13.6 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 13.7 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 13.8 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 13.9 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 13.10 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 13.11 Latin America Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 13.12 Brazil Nasal Drug Delivery Technology Market Analysis
  • 13.13 Mexico Nasal Drug Delivery Technology Market Analysis
  • 13.14 Argentina Nasal Drug Delivery Technology Market Analysis
  • 13.15 Colombia Nasal Drug Delivery Technology Market Analysis
  • 13.16 Chile Nasal Drug Delivery Technology Market Analysis
  • 13.17 Rest of Latin America Nasal Drug Delivery Technology Market Analysis

14 MEA Nasal Drug Delivery Technology Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Nasal Drug Delivery Technology Market Attractiveness Index
  • 14.3 MEA Nasal Drug Delivery Technology Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 14.4 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Country
  • 14.5 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Containers
  • 14.6 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by System
  • 14.7 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Dosage Form
  • 14.8 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Application
  • 14.9 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Respiratory Diseases
  • 14.10 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by Non-respiratory Diseases
  • 14.11 MEA Nasal Drug Delivery Technology Market Size Estimation and Forecast by End-users
  • 14.12 GCC Nasal Drug Delivery Technology Market Analysis
  • 14.13 South Africa Nasal Drug Delivery Technology Market Analysis
  • 14.14 Turkey Nasal Drug Delivery Technology Market Analysis
  • 14.15 Egypt Nasal Drug Delivery Technology Market Analysis
  • 14.16 Rest of MEA Nasal Drug Delivery Technology Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2022
  • 15.2 Strategic Outlook
  • 15.3 Becton, Dickinson, and Company
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2022
      • 15.3.3.2 R&D, 2017-2022
      • 15.3.3.3 Regional Market Shares, 2022
      • 15.3.3.4 Segment Market Shares, 2022
    • 15.3.4 Product Benchmarking
  • 15.4 GSK plc
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2022
      • 15.4.3.2 R&D, 2017-2022
      • 15.4.3.3 Regional Market Shares, 2022
      • 15.4.3.4 Business Segment Market Shares, 2022
    • 15.4.4 Product Benchmarking
  • 15.5 Johnson & Johnson
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2017-2022
      • 15.5.3.2 R&D, 2017-2022
      • 15.5.3.3 Regional Market Shares, 2022
      • 15.5.3.4 Business Segment Market Shares, 2022
    • 15.5.4 Product Benchmarking
    • 15.5.5 Strategic Outlook
  • 15.6 Merck & Co., Inc
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2022
      • 15.6.3.2 R&D, 2017-2022
      • 15.6.3.3 Regional Market Shares, 2022
      • 15.6.3.4 Business Segment Market Shares, 2022
    • 15.6.4 Product Benchmarking
  • 15.7 Novartis AG
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2022
      • 15.7.3.2 R&D, 2017-2022
      • 15.7.3.3 Regional Market Shares, 2022
      • 15.7.3.4 Business Segment Market Shares, 2022
    • 15.7.4 Product Benchmarking
  • 15.8 Teva Pharmaceutical Industries Ltd.
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2022
      • 15.8.3.2 R&D, 2017-2022
      • 15.8.3.3 Regional Market Shares, 2022
      • 15.8.3.4 Business Segment Market Shares, 2022
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 AptarGroup, Inc
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2017-2022
      • 15.9.3.2 R&D, 2017-2022
      • 15.9.3.3 Regional Market Shares, 2022
      • 15.9.3.4 Business Segment Market Shares, 2022
    • 15.9.4 Product Benchmarking
    • 15.9.5 Strategic Outlook
  • 15.10 AstraZeneca PLC
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2022
      • 15.10.3.2 R&D, 2017-2022
      • 15.10.3.3 Regional Market Shares, 2022
      • 15.10.3.4 Business Segment Market Shares, 2022
    • 15.10.4 Product Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 Presspart Verwaltungs GmbH
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Product Benchmarking
    • 15.11.4 Strategic Outlook
  • 15.12 Recipharm AB
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Product Benchmarking
    • 15.12.4 Strategic Outlook
  • 15.13 Neurelis Inc.
    • 15.13.1 Company Snapshot
    • 15.13.2 Overview
    • 15.13.3 Product Benchmarking
    • 15.13.4 Strategic Outlook
  • 15.14 PendoPharm Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Product Benchmarking
  • 15.15 Naveh Pharma Ltd.
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Product Benchmarking
  • 15.16 Dr. Reddy's Laboratories
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Financial Analysis
      • 15.16.3.1 Net Revenue, 2017-2022
      • 15.16.3.2 R&D, 2017-2022
      • 15.16.3.3 Regional Market Shares, 2022
      • 15.16.3.4 Business Segment Market Shares, 2022
    • 15.16.4 Product Benchmarking
  • 15.17 Pfizer Inc
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Financial Analysis
      • 15.17.3.1 Net Revenue, 2017-2022
      • 15.17.3.2 R&D, 2017-2022
      • 15.17.3.3 Regional Market Shares, 2022
      • 15.17.3.4 Business Segment Market Shares, 2022
    • 15.17.4 Product Benchmarking
    • 15.17.5 Strategic Outlook
  • 15.18 Nemera
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Product Benchmarking
    • 15.18.4 Strategic Outlook
  • 15.19 Teleflex Incorporated
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Product Benchmarking
  • 15.20 Optinose US, Inc
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Product Benchmarking
  • 15.21 Flo Nasal Solution
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Product Benchmarking
  • 15.22 Bayer AG
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Financial Analysis
      • 15.22.3.1 Net Revenue, 2017-2022
      • 15.22.3.2 R&D, 2017-2022
      • 15.22.3.3 Regional Market Shares, 2022
      • 15.22.3.4 Business Segment Market Shares, 2022
    • 15.22.4 Product Benchmarking

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from
  • 16.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제